Shanghai Henlius Biotech, Inc. (2696.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 27.97B |
| Enterprise Value | 30.8B |
| P/E Ratio | 26.51 |
| PEG Ratio | 5.76 |
| Price/Sales Ratio | 3.09 |
| Price/Book Ratio | 5.06 |
| Enterprise/Revenue | 3.51 |
| Enterprise/EBITDA | 20.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.2 |
Income Statement
| Revenue | 6.67B |
| Revenue/Share | 13.65 |
| Gross Profit | 4.98B |
| EBITDA | 1.25B |
| Net Income | 805.64M |
| Diluted EPS | 1.47 |
Balance Sheet
| Total Cash | 956.03M |
| Total Cash/Share | 1.75 |
| Total Debt | 3.95B |
| Total Debt/Equity | 0.87 |
| Current Ratio | 0.78 |
| Book Value Per Share | 8.33 |
Price History
| 52-Week Change | -30.52 |
| 52-Week High | 87.1 |
| 52-Week Low | 47.62 |
| Moving Average 50 Days | 61.94 |
| Moving Average 200 Days | 65.59 |
Statistics
| Average Volume | 964,944 |
| Shares Outstanding | 545.2M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
